维普中文期刊产品整合服务
196篇 您的检索式:作者名="BARNETT AH"
    题名 作者 年代 出处 被引量
1An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin ( Exubera) with mefformin as adjuctive therapy in patients with type 2 diabetes poorly controlled on a sulfonylurea显示文摘Barnett AH Dreyer M Lange P 2006Diabetes Care2006,29,6:1
2Saxagliptin add-on therapy to insulin with or without metformin for type 2 diabetes mellitus: 52-week safety and efficacy显示文摘Barnett AH Charbonnel B Li J 2013Clin Drug Investig2013,33,:1
3Factors associated with injection omission/non-adherence in the Global Attitudes of Patients and Physicians in Insulin Therapy study显示文摘Peyrot M Barnett AH Meneghini LF 2012Diabetes Obes Metab2012,14,:1
4Tumor necrosis factor-alpha exerts dual effects on human adipose leptin synthesis and release显示文摘Zhang HH Kumar S Barnett AH 2000Mol Cell Endocrinol2000,159,12:1
5An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin ( Exubera) with glibenclamide as adjuctive therapy in patients with type 2 diabetes poorly controlled on mefformln显示文摘Barnett AH Dreyer M Lange P 2006Diabetes Care2006,29,8:1
6Effect of linagliptin monotherapy on glycaemic control and markers of β-cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial显示文摘Del Prato S Barnett AH Huisman H 2011Diabetes Obes Metab2011,13,3:1
7Dexamethasone inhibits tumor Necrosis factor-alpha-induced apoptosis and interleukin-1beta release In human subcutaneous adipocytes and preadipocytes显示文摘Zhang HH Kumar S Barnett AH 2001J Ciin Endocrinol Metab2001,86,6:1
8Angiotensin-re- ceptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy显示文摘Barnett AH Bain SC Bouter P 2004N Engl d Med2004,351,19:1
9Renal protection with an- giotensin receptor blockers: where do we stand 显示文摘Schmieder RE Ruilope LM Barnett AH 2011J Nephro12011,24,5:1
10Exenatide compared with long-acting insulin to achieve glycaemic control with minimal weight gain in patients with type 2 diabetes: results of the Helping Evaluate Exenatide in patients with diabetes compared with LongActing insulin ( HEELA) study 显示文摘Davies MJ Donnelly R Barnett AH 2009Diabetes Obes Metab2009,11,12:1
11SGLT inhibitors in management of diabetes 显示文摘Tahrani AA Barnett AH Bailey CJ 2013Lancet Diabetes Endocrinol2013,1,:1
12The importance of treating cardiometabolic risk factors in patients with type 2 diabetes显示文摘Barnett AH 2008Diab Vasc Dis Res2008,5,1:1
13Free radical and anti-oxidant systems in health and disease显示文摘Sinclair AJ Barnett AH Lunec J 1990Br J Hosp Med1990,43,5:1
14Preventing renal complications in diabetic patients:the Diabetics Exposed to Telmisartan And enalaprIL (DETAIL) study显示文摘Barnett AH 2005Acta Diabetol2005,421,:1
15Willingness to pay for improvements in chronic long-acting insulin therapy in individuals with type l or type 2 diabetes mellitus显示文摘Lloyd A Nafees B Barnett AH 2011Clin Ther2011,33,9:1
16Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover nonin-feriority trial显示文摘Barnett AH Burger J Johns D 2007Clin Ther2007,29,11:1
17Preventing renal complications in diabetic patients: the diabetics exposed to telmisartan and enalaprlL (DETAIL) study显示文摘Barnett AH 2005Acta Diabetol2005,42,1:1
18Effect of saxagliptin as add-on therapy in patients with poorly controlled type 2 diabetes on insulin alone or insulin combined with metformin 显示文摘Barnett AH Charbonnel B Donovan M 2012Curt Med Res Opin2012,28,4:1
19Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipi- daemia 显示文摘Barnett AH Mackin P Chandhry I 2007J Psvchooharmacol2007,214,:1
20A review of bassl insulins显示文摘BARNETT AH 2003Diabet Med2003,20,11:1
返回顶部 每页显示:
共10页 首页 上一页 第1页 下一页 末页 /10 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费